American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Evofem Biosciences, Inc. (EVFM)

$0.01 +4.69% OTC: EVFM · 15-min delayed

SAN DIEGO, California
Public · OTC: EVFM

Visit website Follow

$20.2MRevenue · FY2025

$391.0KNet income

EVFMOTC

About Evofem Biosciences, Inc.

EVOFEM BIOSCIENCE INC

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Company facts

Type: Public · OTC: EVFM
Headquarters: SAN DIEGO, California
Industry: Pharmaceuticals
Website: Visit site

Registry IDs

Ticker: EVFM OTC
SEC CIK: 1618835
EIN: 208527075
SIC: 2834 Pharmaceutical Preparations

Explore our data studies: the biggest company in every US state · all rankings & reports.

Embed this company’s badge

Show Evofem Biosciences, Inc.’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/evofem-biosciences-inc/"><img src="https://americancompanies.com/badge/evofem-biosciences-inc.svg" alt="Evofem Biosciences, Inc. — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it free, control the page, and activate the embeddable Verified badge for their own website.

Claim this profile — free

Track American companies

Create a free account to follow Evofem Biosciences, Inc. and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Revenue FY2025: $20.2M
Net income: $391.0K
Total assets: $20.3M

Source: SEC EDGAR · updated Jun 8, 2026

OTC: EVFM

$0.01 +4.69%

15-minute delayed · data by Polygon.io

Past year · hover for prices

Open: —
Day range: –
Prev close: —
Volume: —

Evofem Biosciences, Inc. (EVFM) Stock Price

Profitable — net income of $391.0K in FY2025.
Trading near its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Evofem Biosciences, Inc..

Write a review

Newsroom

News about Evofem Biosciences, Inc.

Favorable Pricing Certificates Issued for Evofem's PHEXX by Emirates Drug Establishment are Launching Step for Commercialization in UAE Benzinga · 2025-11-21 · positive Evofem Reports Financial Results for Third Quarter of 2025, Provides Business Update Benzinga · 2025-11-13 · positive Evofem Announces Voting Results from Special Meeting of Stockholders Benzinga · 2025-10-20 · neutral Evofem's SOLOSEC Submitted for Marketing Approval in United Arab Emirates Benzinga · 2025-10-01 · positive Evofem Biosciences Honors World Contraception Day Benzinga · 2025-09-26 · positive SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MLNK, BFIN, MRCC, EVFM on Behalf of Shareholders GlobeNewswire Inc. · 2025-09-11 · neutral

News & sentiment via Polygon.io

FAQ

Evofem Biosciences, Inc.: frequently asked questions

Is Evofem Biosciences, Inc. an American company?

Evofem Biosciences, Inc. is a US-based company headquartered in San Diego, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Evofem Biosciences, Inc. headquartered?

Evofem Biosciences, Inc. is headquartered in San Diego, California, United States.

Is Evofem Biosciences, Inc. publicly traded?

Yes — Evofem Biosciences, Inc. is a publicly traded company. Its stock trades under the ticker symbol EVFM on the OTC.

What does Evofem Biosciences, Inc. do?

Evofem Biosciences, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore